CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today B…
Author: Business Wire
Ray Therapeutics Receives $4M in Funding From the California Institute for Regenerative Medicine (CIRM)
SAN DIEGO–(BUSINESS WIRE)–Ray Therapeutics Receives $4M in Funding from The California Institute For Regenerative Medicine (CIRM)
US Eye Partners with Kelly Eye Center, Raleigh-based Leader in Eye Care
RALEIGH, N.C.–(BUSINESS WIRE)– #Eyecare–US Eye has expanded its presence in North Carolina with the addition of Kelly Eye Center, founded by Michael Kelly, M.D.
Sunvera Group Announces New Partnership with Wilkinson Eye Center
BINGHAM FARMS, Mich.–(BUSINESS WIRE)–Sunvera Group, a portfolio company of Ridgemont Equity Partners, forms a new partnership with Wilkinson Eye Center, expanding their Michigan presence.
Global Human Augmentation Market Outlook to 2027 by Functionality, Product Type, Application, and Region – A $385+ Billion Opportunity Assessment – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Human Augmentation Market By Functionality, By Product Type, By Application, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027” report has been added to ResearchAndMarkets.com’s offering. The Glo…
Lineage Announces a Fifth Cell Therapy Program: Allogeneic Photoreceptor Transplants for the Treatment of Diseases Which May Lead to Blindness
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced a…
Ocular Therapeutix™ to Present Pre-Clinical and Clinical Data at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced multiple scien…
NovaBay Pharmaceuticals CEO Issues Letter to Stockholders
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that Chief Executive Officer Justin Hall has issued the following Letter to Stockholders: To My Fellow Stockholders: I am pleased to report that we have …
Théa Introduces iVIZIA™ OTC Eye-Care Products in U.S.
LEXINGTON, Mass.–(BUSINESS WIRE)–Théa Pharma Inc. (“Théa”), the U.S. subsidiary of Europe’s leading independent pharmaceutical company specializing in the research, development and commercialization of eye-care products, today announced the availabil…
Alcon’s SMARTCataract Demonstrates Enhanced Efficiency and Time Savings for Cataract Surgeries
GENEVA–(BUSINESS WIRE)–Alcon’s SMARTCataract Demonstrates Enhanced Efficiency and Time Savings for Cataract Surgeries
Harrow Health to Participate in B. Riley Securities’ Annual Neuro & Ophthalmology Investor Conference
NASHVILLE, Tenn.–(BUSINESS WIRE)–Harrow Health, Inc. (Nasdaq: HROW), an ophthalmic‑focused healthcare company, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in the B. Riley Secu…
Frequency Therapeutics to Participate in B. Riley Securities’ Neuro & Ophthalmology Investor Conference
LEXINGTON, Mass.–(BUSINESS WIRE)–Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person’s innate regenerative potential to restore function, today announced …
ModMed at ASCRS-ASOA 2022: Modernizing Eye Care with the Latest Platform Release
BOCA RATON, Fla.–(BUSINESS WIRE)–ModMed® today unveiled its latest platform innovations designed to increase clinical efficiencies that can help eye care providers thrive in a complex and demanding healthcare environment. With the constant shifts in …
Warby Parker Publishes Its 2021 Impact Report
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today published its 2021 Impact Report. The Company tracks and publicly reports its impact on stakeholders in thi…
EyeCare Partners Appoints Antonio Capone, Jr. as Chief Clinical Officer
ST. LOUIS–(BUSINESS WIRE)–EyeCare Partners appoints Antonio Capone, Jr. as Chief Clinical Officer.
Aldeyra Therapeutics Announces Presentation of Clinical Data at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced that results from the run-in …
Humana Announces Agreement to Divest Majority Interest in Kindred at Home Hospice and Personal Care Divisions to Clayton, Dubilier & Rice
LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (NYSE: HUM) today announced that it has signed a definitive agreement with private investment firm Clayton, Dubilier & Rice (“CD&R”) to divest a majority interest in the Hospice and Personal Care di…
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that …
Samsara Vision to Initiate a U.S. PMA Supplemental Study of the SING IMT™, a New-Generation Technology for Age-Related Macular Degeneration
FAR HILLS, N.J.–(BUSINESS WIRE)– #AMD–Samsara Vision to Initiate a U.S. PMA Supplemental Study of the SING IMT™, a New-Generation Technology for Age-Related Macular Degeneration
Aerie Pharmaceuticals Announces Presentations at the American Society of Cataract and Refractive Surgery (ASCRS 2022) in Washington, D.C., April 22-26, 2022
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company focused on the discovery, development and commercialization of first-in-class ophthalmic therapies, today announced that three abstracts will be present…